Related Experiment Video
Updated: Aug 29, 2026

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
Published on: June 29, 2013
Relationship between monitoring parameters and perinatal outcome in severe, early intrauterine growth restriction
C M Bilardo1, H Wolf, R H Stigter
1Department of Obstetrics and Gynecology, Academic Medical Center, Amsterdam, The Netherlands. C.M.Bilardo@AMC.UVA.NL
Insights
Ductus venosus pulsatility index (DV PIV) is the most effective predictor of adverse perinatal outcomes in severe early intrauterine growth restriction (IUGR). This finding can help optimize delivery timing for improved fetal health.
Area of Science:
- Perinatal Medicine
- Fetal Physiology
- Neonatal Outcomes
Background:
- Severe early intrauterine growth restriction (IUGR) poses significant risks to fetal well-being.
- Monitoring fetal well-being in IUGR is crucial for timely intervention.
- Existing monitoring methods require further validation for predicting perinatal outcomes.
Purpose of the Study:
- To evaluate the predictive value of umbilical artery (UA) and ductus venosus (DV) Doppler parameters, along with short-term fetal heart rate variation (STV), for perinatal outcomes in severe early IUGR.
- To determine the optimal timing for assessing these parameters in relation to delivery.
Main Methods:
- A multicenter, prospective, observational study involving 70 singleton pregnancies with severe early IUGR.
- Regular assessment of fetal heart rate STV, UA pulsatility index (UA PI), and DV pulsatility index for veins (DV PIV) up to 24 hours before delivery.
- Adverse perinatal outcome defined as perinatal death, severe cerebral hemorrhage, or bronchopulmonary dysplasia.
Main Results:
- Adverse perinatal outcome occurred in 26% of infants.
- DV PIV was significantly higher in the adverse outcome group within 24 hours and 2-7 days before delivery.
- DV PIV, adjusted for gestational age (GA), significantly predicted adverse outcomes at various time points (0-1, 2-7, and 8-14 days prior to delivery).
Conclusions:
- DV PIV measurement is the strongest predictor of perinatal outcome in severe early IUGR.
- DV PIV monitoring may aid in optimizing delivery timing to improve perinatal outcomes.
- Further randomized trials are needed to confirm the clinical utility of DV PIV in managing IUGR pregnancies.
Objective:
To investigate whether pathological changes in the umbilical artery (UA), ductus venosus (DV) and short-term fetal heart variation are related to perinatal outcome in severe, early intrauterine growth restriction (IUGR).
Methods:
This multicenter, prospective, longitudinal, observational study was carried out in the Departments of Fetal Medicine and Obstetrics in Hamburg, Amsterdam, Utrecht and London. In 70 singleton pregnancies with IUGR fetuses, delivered at 26-33 weeks of gestation because of antepartum fetal distress, short-term variation (STV) of fetal heart rate, pulsatility index of the fetal UA (UA PI) and DV pulsatility index for veins (DV PIV) were assessed at least weekly. The final measurement was performed within 24 h of delivery. Standard cut-off levels (2 SD or 3 SD, absent flow or reversed flow) were used and new cut-off levels were calculated by means of receiver-operating characteristics analysis. Adverse outcome was defined as perinatal death, cerebral hemorrhage (> or = Grade II) or bronchopulmonary dysplasia before discharge. The predictive value for adverse outcome was calculated for different cut-off levels of the monitoring parameters, adjusted for gestational age (GA), by multivariate logistic regression analysis. Data were analyzed separately for three different time blocks, namely 8-14, 2-7 and 0-1 days before delivery.
Results:
Adverse perinatal outcome occurred in 18/70 (26%) infants. During the last 24 h before delivery DV PIV and UA PI were significantly higher and STV lower in the adverse outcome group, while 2-7 days before delivery only DV PIV was significantly higher. Adverse perinatal outcome could be predicted at 0-1 days before delivery by DV PIV at a cut-off of three multiples of the SD (odds ratio (OR) 11.3; 95% CI 2.3-57) and GA (OR 0.4; 95% CI 0.3-0.8), at 2-7 days by DV PIV at 2 SD (OR 3.0; 95% CI 0.8-12) and GA (OR 0.5; 95% CI 0.3-0.8) and at 8-14 days by DV PIV at 2 SD (OR 3.9; 95% CI 0.8-20) and GA (OR 0.5; 95% CI 0.3-0.8). Other parameters did not contribute to the multivariate model.
Conclusions:
DV PIV measurement is the best predictor of perinatal outcome. This measurement may be useful in timing the delivery of early IUGR fetuses and in improving perinatal outcome, even when delivery may be indicated at an earlier GA. However, as GA was also an important factor influencing outcome, with poorer outcome at earlier gestation at delivery, this hypothesis needs to be tested in a multicenter, prospective, randomized trial.

